Betaxolol HCl 0.5 % Ophthalmic Solution
RxNorm 308720
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 308720 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: betaxolol HCl 0.5 % Ophthalmic Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Betaxolol 5 mg/ML Ophthalmic Solution
(Atom ID: 12340749)
PTPrescribable
Designated preferred name (PT):
Betaxolol (as betaxolol hydrochloride) 5 mg/mL eye drops
(Atom ID: 10294962)
SYPrescribable
Synonym (SY):
Betaxolol 0.5 % Ophthalmic Solution
(Atom ID: 5938291)
SYPrescribable
Synonym (SY):
Betaxolol 5 mg/ML (betaxolol hydrochloride 5.6 mg/ML) Ophthalmic Solution
(Atom ID: 3805273)
PSNPrescribable
Prescribable Name (PSN):
Betaxolol HCl 0.5 % Ophthalmic Solution
(Atom ID: 6812288)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely betaxolol (as betaxolol hydrochloride) 5 mg/1 mL conventional release eye drops (clinical drug)
(Atom ID: 10309877)
Patient Education
Betaxolol Ophthalmic
Ophthalmic betaxolol is used to treat glaucoma, a condition in which increased pressure in the eye can lead to gradual loss of vision. Betaxolol is in a class of medications called beta blockers. It works by decreasing the pressure in the eye.
[Learn More]
* Please review the disclaimer below.